"To BCG or not to BCG, that is the question!". The challenge of BCG vaccination: Why can't we get it right?

Paediatrics and Child Health

Volumn 8, Issue 3, 2003, Pages 141-144

  Vaudry, Wendy ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ABSCESS; BCG VACCINATION; CANADA; CHILDHOOD MORTALITY; DRUG EFFICACY; DRUG SAFETY; ENVIRONMENTAL EXPOSURE; HIGH RISK POPULATION; HUMAN; INFANT; INFECTION; INFECTION CONTROL; INFECTION RISK; LUNG TUBERCULOSIS; LYMPHADENITIS; LYMPHADENOPATHY; NOTE; OSTEITIS; RISK BENEFIT ANALYSIS; ULCER;

EID: 0038013858     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/8.3.141     Document Type: Note

References (25)

1. Advisory Council for the Elimination of Tuberculosis (ACET) and the Advisory Committee on Immunization Practices. The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States. MMWR 1996;45;1-18.
2. National Advisory Committee on Immunization. BCG Vaccine. In: Population and Public Health Branch; Centre for Infectious Disease Prevention and Control, eds. National Immunization Guide, 6th edn. Ottawa: Canadian Medical Association, 2002:71-6.
3. Health Canada. Tuberculosis in Canada 2000. Ottawa: Health Canada (in press). 〈http://www.hc-sc.gc.ca/pphb-dgspsp〉 (Version current at March 10, 2003).
4. Tuberculosis in First Nations Communities, 1999. Ottawa: Health Canada. 〈http://www.hc-sc.gc.ca/pphb-dgspsp〉 (Version current at March 10, 2003).
5. Starke JR. Tuberculosis of the central nervous system in children. Semin Pediatr Neurol 1999;6:318-31.
6. Fine PEM. Bacille Calmette-Guerin Vaccines: A Rough Guide. Clin Infect Dis 1995;20:11-4.
7. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: A metaanalysis. Int J Epidemiol 1993;22:1154-8.
8. Colditz GA, Berkey S, Mosteller F, et al. The efficacy of Bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: Meta-analyses of the published literature. Pediatrics 1995;96:29-35.
9. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA 1994;271:698-702.
10. Ponnighaus JM, Fine PE, Sterne JA, et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 1992;339:636-9.
11. Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet 1996;348:611.
12. Fordham von Reyn C, Vuola JM. New vaccines for the prevention of tuberculosis. Clin Infect Dis 2002;35:465-74.
13. Aronson JD. Protective vaccination against tuberculosis with special reference to BCG vaccination. Am Rev Tuberc 1948;48:255-81.
14. Ferguson RG, Simes AB. BCG vaccination of infant Indians in Saskatchewan. Tubercle 1949;30:5-11.
15. Rosenthal SR, Loewinsohn E, Graham ML, Liveright D, Thorne MG, Johnson V. BCG vaccination in tuberculous households. Am Rev Respir Dis 1960;84:690-704.
16. Rosenthal SR, Loewinsohn E, Graham ML, et al. BCG vaccination against tuberculosis in Chicago: A twenty-year study statistically analyzed. Pediatrics 1961;28:622-41.
17. Houston S, Fanning A, Soskolne CL, Fraser N. The effectiveness of Bacillus Calmette-Guerin (BCG) vaccination against tuberculosis. Am J Epidemiol 1990;131:340-8.
18. Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999;284:1520-3.
19. Young T, Hershfield E. A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians. Am J Public Health 1986;76:783-6.
20. Turnbull FM, McIntyre PB, Achat HM, et al. National study of adverse reactions after vaccination with Bacille Calmette-Guerin. Clin Infect Dis 2002;34:447-53.
21. Kroger L, Korppi M, Brander E, et al. Osteitis caused by Bacille Calmette-Guerin vaccination: A retrospective analysis of 222 cases. J Infect Dis 1995;172:574-6.
22. Albot EA, Perkins MD, Silva SFM, Frothingham R. Disseminated Bacille Calmette-Guerin disease after vaccination: Case report and review. Clin Infect Dis 1997;24:1139-46.
23. Hutmacher M, Scheifel D, Law B, Halperin S. Hospital admissions for BCG vaccine complications: IMPACT hospitals, 1993-2001. Abstract P20, 5th Canadian National Immunization Conference, Victoria, British Columbia. December 1-3, 2002.
24. Romanus V, Svensson A, Hallander HO. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989. Tuber Lung Dis 1992;73:150-61.
25. Romanus V, Hallander HO, Wahlen P, Olinder-Nielsen AM, Magnusson PH, Juhlin I. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. Tuber Lung Dis 1995;76:300-10.